| HWLAX | VIVIX | HWLAX / VIVIX | |
| Total Expense Ratio | 1.18 | 0.04 | 2,950% |
| Annual Report Gross Expense Ratio | 1.18 | 0.04 | 2,950% |
| Fund Existence | 24 years | 28 years | - |
| Gain YTD | 2.101 | 5.999 | 35% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 360M | 218B | 0% |
| Annual Yield % from dividends | 1.37 | 1.96 | 70% |
| Returns for 1 year | 8.07 | 15.08 | 54% |
| Returns for 3 years | 10.66 | 41.04 | 26% |
| Returns for 5 years | 29.48 | 66.28 | 44% |
| Returns for 10 years | 126.54 | 167.19 | 76% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMVRX | 11.78 | 0.16 | +1.38% |
| RBC Emerging Markets Value Equity R6 | |||
| PEQSX | 41.22 | 0.26 | +0.63% |
| Putnam Large Cap Value R6 | |||
| GSRRX | 10.87 | -0.08 | -0.73% |
| Goldman Sachs Rising Dividend Gr R | |||
| MALRX | 24.64 | -0.21 | -0.85% |
| BlackRock Advantage Large Cap Core Instl | |||
| LYRIX | 28.33 | -0.75 | -2.58% |
| Lyrical US Value Equity Institutional | |||